Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05142358 · ClinicalTrials.gov registry record · NA
A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose
A NA study of Lung Cancer and Left Sided Breast Cancer, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT05142358 is a NA study of Lung Cancer and Left Sided Breast Cancer that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 8 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05142358, a NA study of Lung Cancer and Left Sided Breast Cancer, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Data collection and assessment on patients with left-sided breast cancer or undergoing lung stereotactic body radiation therapy (SBRT) utilizing continuous positive airway pressure (CPAP) devices.
Conditions Studied
Interventions
- DEVICE Continuous Positive Airway Pressure
- OTHER Deep inspiratory breath hold
- OTHER Free Breath
Study Locations (1)
Ohio
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-10-19 |
| Est. Completion | 2026-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05142358
The ClinicalTrials.gov registry entry for NCT05142358 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which Continuous Positive Airway Pressure is the first listed.
NCT05142358 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05142358 about?
NCT05142358 is a clinical study titled "A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose". Data collection and assessment on patients with left-sided breast cancer or undergoing lung stereotactic body radiation therapy (SBRT) utilizing continuous positive airway pressure (CPAP) devices.
What is the current status of trial NCT05142358?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2022-10-19. Estimated completion is 2026-01-28.
What conditions does trial NCT05142358 study?
This clinical trial studies the following conditions: Lung Cancer, Left Sided Breast Cancer.
What interventions are being tested in trial NCT05142358?
The interventions under investigation include: Continuous Positive Airway Pressure (DEVICE), Deep inspiratory breath hold (OTHER), Free Breath (OTHER).
Who is sponsoring clinical trial NCT05142358?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05142358 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.